Quinidine has also been tested in SQTS patients with KCNQ1, KCNJ2, CACNA1C and CACNB2 variants, but the number of patients included in these studies is too small to determine its efficacy. The gene discussed is CACNA1C; the disease is Familial short QT syndrome.